Characteristics and reasons associated with non-acceptance of selective serotonin reuptake inhibitor treatment

被引：0
|
作者：
van Geffen, Erica Cg [1 ]
van Hulten, Rolf [1 ]
Bouvy, Marcel L. [2 ]
Egberts, Antoine C. G. [1 ]
Heerdink, Eibert R. [1 ]
机构：
[1] Utrecht Inst Pharmaceut Sci, Dept Pharmacoepidemiol & Pharmacotherapy, Utrecht, Netherlands
[2] SIR Inst Pharm & Policy, Leiden, Netherlands
来源：
PHARMACY WORLD & SCIENCE | 2008年 / 30卷 / 05期
关键词：
antidepressants; discontinuation; nonadherence;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：658 / 658
页数：1
相关论文
共 50 条
  • [21] Diminished Neural Processing of Aversive and Rewarding Stimuli During Selective Serotonin Reuptake Inhibitor Treatment
    McCabe, Ciara
    Mishor, Zevic
    Cowen, Philip J.
    Harmer, Catherine J.
    BIOLOGICAL PSYCHIATRY, 2010, 67 (05) : 439 - 445
  • [22] Fatal Serotonin Syndrome Precipitated by Oxcarbazepine in a Patient Using an Selective Serotonin Reuptake Inhibitor
    Dardis, Christopher
    Omoregie, Eghosa
    Ly, Vanthanh
    NEUROLOGIST, 2012, 18 (04) : 204 - 205
  • [23] THE SEROTONIN REUPTAKE INHIBITOR PAROXETIN IS SUPERIOR TO THE NORADRENALINE REUPTAKE INHIBITOR MAPROTILINE IN THE TREATMENT OF PREMENSTRUAL-SYNDROME
    ERIKSSON, E
    HEDBERG, MA
    ANDERSCH, B
    SUNDBLAD, C
    NEUROPSYCHOPHARMACOLOGY, 1995, 12 (02) : 167 - 176
  • [24] Selective Serotonin Reuptake Inhibitor Usage Patterns as Risk Factors for Hospitalization
    Reinée E. Sheffield
    Anthony T. Lo Sasso
    Christopher H. Young
    Karen Way
    Administration and Policy in Mental Health and Mental Health Services Research, 2002, 30 : 121 - 139
  • [25] Selective serotonin reuptake inhibitor effects on neural biomarkers of perinatal depression
    Pawluski, Jodi L.
    Brain, Ursula
    Hammond, Geoffrey L.
    Oberlander, Tim F.
    ARCHIVES OF WOMENS MENTAL HEALTH, 2019, 22 (03) : 431 - 435
  • [26] Metabolic drug interactions with selective serotonin reuptake inhibitor (SSRI) antidepressants
    Baker, GB
    Fang, J
    Sinha, S
    Coutts, RT
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 1998, 22 (02) : 325 - 333
  • [27] Selective serotonin reuptake inhibitor usage patterns as risk factors for hospitalization
    Sheffield, RE
    Lo Sasso, AT
    Young, CH
    Way, K
    ADMINISTRATION AND POLICY IN MENTAL HEALTH, 2002, 30 (02): : 121 - 139
  • [28] N-methyl-citalopram: A quaternary selective serotonin reuptake inhibitor
    Bismuth-Evenzal, Yona
    Roz, Netta
    Gurwitz, David
    Rehavi, Moshe
    BIOCHEMICAL PHARMACOLOGY, 2010, 80 (10) : 1546 - 1552
  • [29] Selective serotonin reuptake inhibitor effects on neural biomarkers of perinatal depression
    Jodi L. Pawluski
    Ursula Brain
    Geoffrey L. Hammond
    Tim F. Oberlander
    Archives of Women's Mental Health, 2019, 22 : 431 - 435
  • [30] Comparison of citalopram and other selective serotonin reuptake inhibitor ingestions in children
    Klein-Schwartz, Wendy
    Benson, Blaine E.
    Lee, Samantha C.
    Litovitz, Toby
    CLINICAL TOXICOLOGY, 2012, 50 (05) : 418 - 423
12345